Hepatocyte growth factor increases uptake of estradiol 17β-d-glucuronide and Oatp1 protein level in rat hepatocytes

European Journal of Pharmacology

Volumn 580, Issue 1-2, 2008, Pages 19-26

  Iwakiri, Tomomi ^a   Okumura, Manabu ^a   Matsunaga, Naoya ^a   Ichihara, Emi ^a   Shiotsuki, Satoshi ^a   Nagata, Masashi ^a   Kumagai, Yuki ^a   Kai, Hirofumi ^b   Arimori, Kazuhiko ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Bile salt; Cholestasis; E217 G; HGF; Oatp1; Rat hepatocyte

Indexed keywords

BROMSULFOPHTHALEIN; DIGOXIN; ESTRADIOL 17 GLUCURONIDE; LITHIUM ION; MESSENGER RNA; OCHRATOXIN; OUABAIN; PROTEIN; PROTEIN ANTIBODY; PROTEIN OATP1; SCATTER FACTOR; SCATTER FACTOR ANTIBODY; SODIUM ION; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; ISOTOPE LABELING; LIVER CELL; LIVER CELL CULTURE; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UBIQUITINATION;

ANIMALS; CELLS, CULTURED; CHOLESTASIS; ESTRADIOL; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; MALE; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; RATS; RATS, WISTAR; RNA, MESSENGER; TAUROCHOLIC ACID; UBIQUITINATION;

EID: 37649018630     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.041     Document Type: Article

References (36)

1. Bissell D.M., Hammaker L.E., and Meyer U.A. Parenchymal cells from adult rat liver in nonproliferating monolayer culture. I. Functional studies. J. Cell Biol. 59 (1973) 722-734
2. Cattori V., van Montfoort J.E., Stieger B., Landmann L., Meijer D.K., Winterhalter K.H., Meier P.J., and Hagenbuch B. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch. 443 (2001) 188-195
3. Donato M.T., Gomez-Lechon M.J., Jover R., Nakamura T., and Castell J.V. Human hepatocyte growth factor down-regulates the expression of cytochrome P450 isozymes in human hepatocytes in primary culture. J. Pharmacol. Exp. Ther. 284 (1998) 760-767
4. Fausto N., Laird A.D., and Webber E.M. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J. 9 (1995) 1527-1536
5. Fickert P., Zollner G., Fuchsbichler A., Stumptner C., Pojer C., Zenz R., Lammert F., Stieger B., Meier P.J., Zatloukal K., Denk H., and Trauner M. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 121 (2001) 170-183
6. Geier A., Dietrich C.G., Gerloff T., Haendly J., Kullak-Ublick G.A., Stieger B., Meier P.J., Matern S., and Gartung C. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim. Biophys. Acta 1609 (2003) 87-94
7. Geier A., Wagner M., Dietrich C.G., and Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim. Biophys. Acta 1773 (2007) 283-308
8. Gohda E., Tsubouchi H., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Miyazaki H., Hashimoto S., and Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J. Clin. Invest. 81 (1988) 414-419
9. Hagenbuch B., Scharschmidt B.F., and Meier P.J. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. Biochem. J. 316 Pt 3 (1996) 901-904
10. Hata S., Wang P., Eftychiou N., Ananthanarayanan M., Batta A., Salen G., Pang K.S., and Wolkoff A.W. Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake. Am. J. Physiol. 285 (2003) G829-G839
11. Huh C.G., Factor V.M., Sanchez A., Uchida K., Conner E.A., and Thorgeirsson S.S. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4477-4482
12. Ido A., Numata M., Kodama M., and Tsubouchi H. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J. Gastroenterol. 40 (2005) 925-931
13. Kim W.H., Matsumoto K., Bessho K., and Nakamura T. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am. J. Pathol. 166 (2005) 1017-1028
14. Kodawara T., Masuda S., Wakasugi H., Uwai Y., Futami T., Saito H., Abe T., and Inu K. Organic anion transporter oatp2-mediated interaction between digoxin and amiodarone in the rat liver. Pharm. Res. 19 (2002) 738-743
15. Kouzuki H., Suzuki H., Ito K., Ohashi R., and Sugiyama Y. Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes. J. Pharmacol. Exp. Ther. 286 (1998) 1043-1050
16. Kouzuki H., Suzuki H., Ito K., Ohashi R., and Sugiyama Y. Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes. J. Pharmacol. Exp. Ther. 288 (1999) 627-634
17. Kullak-Ublick G.A., Stieger B., and Meier P.J. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126 (2004) 322-342
18. Meier P.J., and Stieger B. Bile salt transporters. Annu. Rev. Physiol. 64 (2002) 635-661
19. Mizuno S., and Nakamura T. Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am. J. Pathol. 166 (2005) 1895-1905
20. Nakamura T., Nawa K., Ichihara A., Kaise N., and Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 224 (1987) 311-316
21. Nishizaki T., Takenaka K., Yoshizumi T., Yanaga K., Soejima Y., Shirabe K., and Sugimachi K. Alteration in levels of human hepatocyte growth factor following hepatectomy. J. Am. Coll. Surg. 181 (1995) 6-10
22. Okada M., Sugita K., Inukai T., Goi K., Kagami K., Kawasaki K., and Nakazawa S. Hepatocyte growth factor protects small airway epithelial cells from apoptosis induced by tumor necrosis factor-alpha or oxidative stress. Pediatr. Res. 56 (2004) 336-344
23. Oswald M., Kullak-Ublick G.A., Paumgartner G., and Beuers U. Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. Liver 21 (2001) 247-253
24. Pauli-Magnus C., and Meier P.J. Hepatobiliary transporters and drug-induced cholestasis. Hepatology 44 (2006) 778-787
25. Pauli-Magnus C., Stieger B., Meier Y., Kullak-Ublick G.A., and Meier P.J. Enterohepatic transport of bile salts and genetics of cholestasis. J. Hepatol. 43 (2005) 342-357
26. Rost D., Herrmann T., Sauer P., Schmidts H.L., Stieger B., Meier P.J., Stremmel W., and Stiehl A. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate. Hepatology 38 (2003) 187-195
27. Selden C., Johnstone R., Darby H., Gupta S., and Hodgson H.J. Human serum does contain a high molecular weight hepatocyte growth factor: studies pre- and post-hepatic resection. Biochem. Biophys. Res. Commun. 139 (1986) 361-366
28. Stolz D.B., Mars W.M., Petersen B.E., Kim T.H., and Michalopoulos G.K. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res. 59 (1999) 3954-3960
29. Ueki T., Kaneda Y., Tsutsui H., Nakanishi K., Sawa Y., Morishita R., Matsumoto K., Nakamura T., Takahashi H., Okamoto E., and Fujimoto J. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat. Med. 5 (1999) 226-230
30. Vos T.A., Hooiveld G.J., Koning H., Childs S., Meijer D.K., Moshage H., Jansen P.L., and Muller M. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28 (1998) 1637-1644
31. Wang L., Soroka C.J., and Boyer J.L. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II. J. Clin. Invest. 110 (2002) 965-972
32. Wang H., Vohra B.P., Zhang Y., and Heuckeroth R.O. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice. Hepatology 42 (2005) 1099-1108
33. Xia X., Roundtree M., Merikhi A., Lu X., Shentu S., and Lesage G. Degradation of the apical sodium-dependent bile acid transporter by the ubiquitin-proteasome pathway in cholangiocytes. J. Biol. Chem. 279 (2004) 44931-44937
34. Xia J.L., Dai C., Michalopoulos G.K., and Liu Y. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am. J. Pathol. 168 (2006) 1500-1512
35. Yoshikawa A., Kaido T., Seto S., Yamaoka S., Sato M., Ishii T., and Imamura M. Hepatocyte growth factor promotes liver regeneration with prompt improvement of hyperbilirubinemia in hepatectomized cholestatic rats. J. Surg. Res. 78 (1998) 54-59
36. Zollner G., Fickert P., Zenz R., Fuchsbichler A., Stumptner C., Kenner L., Ferenci P., Stauber R.E., Krejs G.J., Denk H., Zatloukal K., and Trauner M. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33 (2001) 633-646